Cardiovascular

BARC offers a wide range of tests for assessement of the cardiovascular risk:

Plaque formation: lipid check-up (including direct assay of LDL cholesterol), lipoprotein a, apolipoproteins A1, B, CIII and E, homocysteine, apo-E genotyping for genetic cardiovascular risk related to hyperlipidemia,...

Plaque rupture: IL-6, TNF-a, ICAM, VCAM, lipoprotein-associated phospholipase A2, MMP-9, MPO, soluble CD40 ligans, P-selectin, CRP-US,...

Myocardial muscle risk: lactate, LDH, AST, CK, CK-MB mass, myoglobin, troponin T and I, FADP,...

Heart dysfunction: BNP, NTproBNP,...

Hypertension

Hypertension is among the most common chronic medical problem faced by healthcare providers. Several tests proposed by BARC help with characterization of hypertension and of its causes, including vasopressin (ADH), HVA, aldosterone, 3 O-methylthyramine, VMA, metanephrines (urine or plasma), renin, catecholamine fractionation, angiotensin II, ...

Pharmacogenomics 

Inter-individual genetic sensitivity to drugs is an area in constant development with more and more discoveries of genes. In addition, interactions between drugs, nutrition, environment and lifestyle are an active field of research where still a lot of discoveries remain to be done, although it is extremely important since it conditions individual drug efficiency and safety. With its large panel of tests in metabolism, pharmacology and pharmacogenomics combined with our clinical pathologists expertise, BARC is the best option for complex clinical studies involving cardiovascular drugs.